Luminate meets primary endpoint in phase 2 trial for dry AMD
8 monthes ago - By Healio
A treatment candidate for dry age-related macular degeneration met its primary endpoint in a phase 2 study, with 48% of patients gaining at least eight letters of vision, according to a press release from Allegro Ophthalmics.
The prospective, randomized, double-masked, placebo-controlled trial evaluated safety and efficacy of Luminate in intermediate dry AMD. Patients in the treatment arm were randomly assigned to receive one 1-mg Luminate intravitreal injection at baseline and a second at week 16, while those in the sham arm received a sham injection at baseline
Read more ...
The headlines of Master Doctor
Apparently There's Going To Be A ‘Bachelor' For Seniors
Bachelor for seniors, please get on my TV right this minute We'd understand if you missed it, considering it was Peter Weber's Fantasy Suite episode and the drama was off the...
Men over 40 who enjoy sex need to worry more about prostate cancer
Jeremy Clarke already had the cancer. But a doctor told his 46-year-old brother he didn't need to be checked. Now they're both fighting for survival.
Is Exercise Good for Hip Arthritis?
Osteoarthritis is the most frequent form of joint disease that people develop with age. You hear a lot about arthritis of the knee, but arthritis also impacts the joints in the...
Surprise! Bone Density and Bone Strength Aren't the Same Thing
All women should be concerned about their bone density and risk of osteoporosis, a serious bone condition where bones become less dense, more fragile, and prone toward...
These Firefighting Twins Shed Their 'Macho' Hang-Ups to Beat Prostate Cancer...
They're teaching other guys how to fight it, too.
VIDEO: New IOLs look to extend depth of focus without decreasing vision quality
MARRAKECH, Morocco - At the European Society of Cataract and Refractive Surgeons Winter Meeting, Richard Packard, MD, speaks about current trends in IOL technology. New options...
Deprescribing Alzheimer's Drugs: The Crowdsourced Opinion
The family wants to simplify an elderly man's medication regimen, but is it the right time to discontinue his Alzheimer's disease treatments? Medscape Family Medicine
Medical Student Mistreatment Higher Among Women, Minorities
Mistreatment from senior physicians, nurses, and staff is more common among medical students who are female, nonwhite, and/or not heterosexual. Medscape Medical News
Dementia rates set to double in Europe by 2050, echoing US estimates
The number of patients with dementia will likely double in Europe by 2050, according to a recent report by Alzheimer Europe. The report is among several large-scale European...
Debating the Value of PSA Prostate Screening
In many men identified as having prostate cancer following PSA screening, the disease is neither aggressive nor likely to kill them before something else does.